The project will study myelin/ oligodendrocyte glycoprotein (MOG) which has been localized on the outermost wrap of the myelin sheath and identified as a major target involved in immune-mediated demyelination. The proposal has three Specific Aims that are overall designed 1) to advance the understanding of MOG and the role it plays in myelination and 2) to begin a molecular analysis of MOG's interactions with the oligodendroglial cytoskeleton. Since preliminary data indicate that MOG interacts with the cytoskeleton, the project will focus on MOG's putative cytoplasmic domains that are most likely to associate with the cytoskeleton.
In Aim 1, MOG's cytoplasmic domains will be mutagenized to generate constructs which in turn will be used to generate multiple stable transfectants of an immortalized oligodendrocyte cell line N20.1.
In Aim 2, MOG/cytoskeleton interactions will be analyzed in wildtype and variant MOG stably expressing N20.1 lines.
In Aim 3, the proposal will focus on characterizing molecules that associate with MOG's intracellular domains, utilizing co-immuno-precipitation and cross-linking experiments.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS035319-01A1
Application #
2038358
Study Section
Special Emphasis Panel (ZRG1-NLS-3 (01))
Program Officer
Kerza-Kwiatecki, a P
Project Start
1997-02-01
Project End
2001-01-31
Budget Start
1997-02-01
Budget End
1998-01-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Pathology
Type
Schools of Dentistry
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611